2013 Global Regulatory Perspectives Workshop Presentations

Session I - Regulatory Developments
Regulatory: Kimberly Benton, PhD, Deputy Director
Division of Cellular and Gene Therapies, Food and Drug Administration (FDA), USA
Regulator: Liz Anne Gillham-Eisen, Manager
Blood, Cells, Tissues and Organs/Office of Policy and International Collaboration/Biologics and Genetic Therapies Directorate, Health Canada, Canada
Regulator:Tetsuya Kusakabe, PhD, MPH, Review Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Session II - Clinical Exemptions from Marketing Authorization
Regulator:Paula Salmikangas, PhD, Assistant Professor, Co-ordinating Senior Researcher
Finnish Medicines Agency (FIMEA), Finland

Regulator: Glenn Smith, Director
Therapeutic Goods Administration (TGA), Australia
Industry: Dominic Wall, PhD, Operations Director
Peter MacCallum Cancer Centre, Australia
Industry: Richard Lilischkis, PhD, Clinical Development Director
Regeneus, Australia

Case Study I
Moderator: Janet Macpherson

Session III - Characterization and Comparability: The Role of Reference Standards and Method Standardization
Regulator:Judith Arcidiacono, MSc, International Regulatory Activities Liaison
Food and Drug Administration (FDA), USA
Regulator:Paula Salmikangas, PhD, Assistant Professor, Co-ordinating Senior Researcher
Finnish Medicines Agency (FIMEA), Finland
Industry:Darin Weber, PhD, EVP
Global Regulatory Affairs, Mesoblast, USA
Academic:Michael Kalos, PhD, Director
Translational and Correlative Studies Laboratory, University of Pennsylvania, USA

Case Study II
Moderator: Christopher Bravery

Session IV - Cells from Banked Tissue - Novel Applications, Regulatory Considerations and Questions
Moderator: Karen Nichols, ESQ. RAC, VP
Regulatory and Quality, PerkinElmer, USA

Regulator: Glyn Stacey, PhD, Director
The UK Stem Cell Bank, United Kingdom
Regulatory: Tony Manderson, Principal Evaluator
Cell and Tissue Unit, Biological Science Station, Therapeutic Goods Administration (TGA), Australia
Regulator: Geeta Jotwani, PhD, Assistant Director General (Scientist D)
Indian Council of Medical Research, India
Industry: Aby J. Mathew, PhD, Senior Vice President and Chief Technology Officer
BioLife Solutions, USA

Case Study III
Moderator: Karen Nichols

© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.